Patents by Inventor Julianne Henry

Julianne Henry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
    Patent number: 8669050
    Abstract: The present invention relates generally to novel nucleic acid molecules, the levels and/or patterns of expression of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm and to derivatives, homologues or analogues of said molecules. More particularly, the present invention is directed to novel nucleic acid molecules, the levels of expression of which are indicative of the onset and/or progression of a gastrointestinal tract neoplasm, such as an adenoma, and to derivatives, homologues or analogues of said molecules. The present invention is further directed to isolated proteins encoded thereby and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of prophylactic, therapeutic and/or diagnostic applications including, but not limited to, those relating to the diagnosis and/or treatment of colorectal neoplasms such as colorectal adenomas.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: March 11, 2014
    Assignee: Clinical Genomics Pty. Ltd.
    Inventors: Robert James, Julianne Henry, Jan Kazenwadel, Nick Van Host Pellekaan, Anne MacPherson, Susan O'Connor
  • Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
    Publication number: 20050053967
    Abstract: The present invention relates generally to novel nucleic acid molecules, the levels and/or patterns of expression of which are indicative of the onset, predisposition to the onset and/or progression of a neoplasm and to derivatives, homologues or analogues of said molecules. More particularly, the present invention is directed to novel nucleic acid molecules, the levels of expression of which are indicative of the onset and/or progression of a gastrointestinal tract neoplasm, such as an adenoma, and to derivatives, homologues or analogues of said molecules. The present invention is further directed to isolated proteins encoded thereby and to derivatives, homologues, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of prophylactic, therapeutic and/or diagnostic applications including, but not limited to, those relating to the diagnosis and/or treatment of colorectal neoplasms such as colorectal adenomas.
    Type: Application
    Filed: March 12, 2004
    Publication date: March 10, 2005
    Applicant: MediMolecular Pty Ltd.
    Inventors: Robert James, Julianne Henry, Jan Kazenwadel, Nick Pellekaan, Anne MacPherson, Susan O'Connor